Skip to main content

Table 1 Histopathological characteristics of EC

From: Risk stratification of endometrial cancer and lymph node metastases prediction using 18F-FDG PET/CT: role of metabolic tumor volume and total lesion glycolysis

Histological characteristic

Number of cases (%)

Histopathological type

Non-endometrioid

5/33 (15.2%)

Endometrioid

28/33 (84.8%)

Histopathological grade

G 1

15/33 (45.5%)

G 2

11/33 (33.3%)

G 3

7/33 (21.2%)

FIGO stage

IA

15/33 (45.5%)

IB

6/33 (18.2%)

II

2/33 (6.1%)

IIIB

1/33 (3%)

IIIC

7/33 (21.2%)

IVB

2/33 (6%)

Myometrial invasion

 < 50%

15/33 (45.5%)

 > 50%

18/33 (54.5%)

LVSI

Yes

15/33 (45.5%)

No

18/33 (54.5%)

LNMs

Yes

9/33 (27.3%)

No

24/33 (72.7%)

Risk stratification

Low risk

11/33 (33.3%)

High risk

22/33 (66.7%)

  1. LVSI, Lymphovascular space invasion, LNMs, Lymph nodes metastases